BioStem Technologies Releases Third Quarter 2018 Shareholder Update
December 10, 2018 11:48 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Dec. 10, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem Technologies” or the “Company”), a global life sciences corporation providing innovative...
Organovo Appoints New Board Member
December 06, 2018 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
Xtant Medical to Issue Third Quarter 2018 Results on November 14, 2018
November 12, 2018 09:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, MT, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today announced...
Organovo Partners With IIAM on Multi-Year Clinical Biomaterial Sourcing Agreement
November 12, 2018 08:05 ET
|
Organovo, Inc.; International Institute for the Advancement of Medicine (“IIAM”)
SAN DIEGO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
Hemostemix Announces Development of an ACP-01 Allogeneic Process and Initiation of R&D for Autologous NCP-01 Neural Cellular Precursors
November 09, 2018 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to provide the following update on its research and...
Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Second-Quarter 2019 Results
November 08, 2018 16:05 ET
|
Organovo, Inc.
Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2019Second orphan designation anticipated in first half of calendar 2019Submit first IND in calendar 2020 ...
Hemostemix Announces Important Manufacturing Process Refinements
November 08, 2018 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that is has completed refinements to its...
The Alliance for Regenerative Medicine Releases Q3 2018 Data Report, Highlighting Sector Trends and Metrics
November 01, 2018 10:17 ET
|
Alliance for Regenerative Medicine
WASHINGTON, DC , Nov. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly data report, offering an in-depth look at...
Predictive Technology Group Appoints Industry Veteran John E. Sorrentino as Chairman
October 30, 2018 09:00 ET
|
Predictive Technology Group, Inc.
Sorrentino Expands Role to Support Goal of Bringing Innovative Technologies to Market SALT LAKE CITY , Oct. 30, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader...
Organovo Announces Release Date for Fiscal Second-Quarter 2019 Financial Results
October 18, 2018 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, November 8, 2018 at 5:00 p.m. Eastern Time (ET) to discuss...